- Home
- FLYW vs RXRX Comparison
FLYW vs RXRX Comparison
Compare FLYW & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLYW | RXRX |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FLYW | RXRX |
|---|---|---|
| Price | $18.55 | $3.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $16.21 | $7.50 |
| AVG Volume (30 Days) | 2.6M | ★ 20.9M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 450.00 | 14.79 |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $623,025,000.00 | $74,681,000.00 |
| Revenue This Year | $19.68 | $12.11 |
| Revenue Next Year | $15.25 | $82.52 |
| P/E Ratio | $183.30 | ★ N/A |
| Revenue Growth | 26.59 | ★ 26.92 |
| 52 Week Low | $10.11 | $2.77 |
| 52 Week High | $18.92 | $7.18 |
Technical Indicators
Market Signals| Indicator | FLYW | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.87 | 63.46 |
| Support Level | $13.15 | $2.88 |
| Resistance Level | N/A | $4.01 |
| Average True Range (ATR) | 0.76 | 0.24 |
| MACD | 0.27 | 0.07 |
| Stochastic Oscillator | 88.11 | 76.96 |
Price Performance
Historical ComparisonAbout FLYW Flywire Corporation Voting
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements, namely a payments platform, a proprietary payment network, and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.